MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings DIO Ratio 2011-2026 | ONVO
Annual DIO Ratio Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 371 | 298 | 210 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 371 | 210 | 293 |
Quarterly DIO Ratio Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 47.8 K | 16.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.23 K | 130 | 151 | 702 | 951 | 949 | 860 | - | 251 | 146 | 154 | - | 166 | 56.5 | 68.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.8 K | 56.5 | 4.65 K |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
97.1 | $ 117.74 | -1.68 % | $ 35.8 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 19.95 | -2.97 % | $ 211 M |  China |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 22.11 | 25.81 % | $ 1.18 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.42 | - | $ 1.89 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 24.49 | -0.53 % | $ 680 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 179.73 | -0.51 % | $ 8.91 B | USA |
 |
Danaher Corporation
DHR
|
87.6 | $ 194.65 | -1.74 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 1.93 | -12.09 % | $ 8.54 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 130.0 | -1.71 % | $ 20.7 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.04 | -0.8 % | $ 485 M | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.39 | -3.34 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.18 | -2.55 % | $ 1.99 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 85.27 | 0.48 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
147 | $ 2.19 | 4.03 % | $ 5.03 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 29.07 | - | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 115.89 | -0.52 % | $ 9.56 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 267.91 | 0.38 % | $ 22.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Senseonics Holdings
SENS
|
104 | $ 6.78 | -1.74 % | $ 283 M | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 5.16 | -0.67 % | $ 478 M | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 83.51 | -0.51 % | $ 5.64 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.62 | 0.1 % | $ 2.67 B | USA |
 |
Neuronetics
STIM
|
20.4 | $ 1.36 | -2.52 % | $ 89.7 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 193.55 | 1.16 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
405 | $ 5.2 | 1.17 % | $ 4.09 M | USA |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 522.74 | -1.65 % | $ 197 B | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |